MDNews - Cleveland-Akron-Canton

November/December 2015

Issue link: http://viewer.e-digitaledition.com/i/589857

Contents of this Issue

Navigation

Page 14 of 43

By M. Jean Uy-Kroh, MD, and Elim Shih, MD The INSPIRE trial is a 12 week research study. We seek to enroll women diagnosed with chronic pelvic pain of greater than 6 months duration. Now Enrolling Subjects Chronic Pelvic Pain CLINICAL TRIAL Chronic Pelvic Pain CLINICAL TRIAL Chronic Pelvic Pain Chronic Pelvic Pain Chronic Pelvic Pain CLINICAL TRIAL Chronic Pelvic Pain Now Enrolling Subjects CLINICAL TRIAL Now Enrolling Subjects Now Enrolling Subjects Now Enrolling Subjects C HRONIC PELVIC PAIN is a complex diagnosis, encompassing multiple different conditions and many organ systems. Treatment of chronic pain is challenging due to an incomplete understanding of pain processing. Pelvic f loor physical therapy is an effective treatment. Rehabilitation addresses the pelvic floor dysfunction and may include manual therapy, transvaginal biofeedback and electrical stimulation. Despite its efficacy and benefits, physical therapy is time intensive and may cause the patient social embarrassment resulting in its inaccessibility. We are actively enrolling subjects in the INSPIRE (INtravaginal Stimulation for Pelvic Pain Improvement and Relief) trial at the Cleveland Clinic which is a randomized controlled trial utilizing a non-implanted intra-vaginal electrical stimulation device within the comfort and privacy of the patient's home. We will deliver pelvic stimulation using a device currently FDA approved for urinary incontinence when used at different power settings. This personal device allows the patient a more active role in her treatment, which can be empowering and therapeutic. The INSPIRE trial is a 12 week research study. We seek to enroll women diagnosed with chronic pelvic pain of greater than 6 months duration. Subjects are randomized into one of two study groups. One study group will use an active device and the other will use a sham (non-functioning) device. The trial requires 4 visits to the Cleveland Clinic main campus. Parking is validated for each visit and subjects are nominally compensated. If the trial proves pain relief with the active device at study conclusion, subjects randomized to the sham arm will be provided the working device at no cost. After enrollment, subjects must commit to perform home sessions using the device 6 times per week, 12 minutes per session, for a total of 12 weeks. Not ever yone will meet criteria for participation in this research project. If you or someone you k now is interested, please ca ll 216-4 4 4-0551 a nd quer y the INSPIRE trial. More information can be found on our website at clevelandclinic.org/inspiretrial. Click on the "clinical studies" tab. Dr. M. Jean Uy-Kroh is a board certified g ynecological surgeon and Director of the Chronic Pelvic Pain Program, Women's Health Institute, at the Cleveland Clinic. Dr. Elim Shih is a board certified family medicine physician and completing fellowship training in Women's Health at the Center for Specialized Women's Health, Women's Health Institute, at the Cleveland Clinic. ■ 2 0 1 5 N OV E M B E R / D E C E M B E R ■ M D N E W S . CO M ■ MD NEWS Cleveland/Akron/Canton | 1 5

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2015